A PHASE III RANDOMIZED TRIAL OF TOPICAL VAGINAL FLUOROURACIL (5-FLUOROURACIL, 5-FU) MAINTENANCE THERAPY VERSUS OBSERVATION AFTER STANDARD TREATMENT FOR HIGH-GRADE CERVICAL DYSPLASIA IN HIV-INFECTED WOMEN: